Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine

PURPOSE: Previously, secondary prevention of herpes zoster required live-attenuated vaccination, which is contraindicated in immunocompromised populations. More recently, a recombinant subunit vaccine (Shingrix, GlaxoSmithKline, Research Triangle Park, North Carolina) was approved by the Food and Dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rebecca I., Deaner, Jordan D., Srivastava, Sunil K., Lowder, Careen Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599389/
https://www.ncbi.nlm.nih.gov/pubmed/33163688
http://dx.doi.org/10.1016/j.ajoc.2020.100962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599389/
https://www.ncbi.nlm.nih.gov/pubmed/33163688
http://dx.doi.org/10.1016/j.ajoc.2020.100962

Ejemplares similares